AGENT SKILL

bio-crispr-screens-crispresso-editing

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

License 许可
Apache-2.0
最近更新
2026-10-12
Stars
★ 2
Forks
0

01 前言 Front Matter

name
bio-crispr-screens-crispresso-editing
tool_type
cli
description
Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.
primary_tool
CRISPResso2

02 资源文件 2

03 SKILL.md 正文

Version Compatibility

Reference examples checked on CRISPResso2 2.3.4 (pinellolab/crispresso2 Docker image), pandas 2.2+, numpy 1.26+, matplotlib 3.8+.

Before using code patterns, verify installed versions match. If versions differ:

  • CLI: CRISPResso --version; CRISPRessoBatch --help; CRISPRessoPooled --help; CRISPRessoWGS --help; CRISPRessoCompare --help
  • Python: from CRISPResso2 import ...

If code throws ImportError, AttributeError, or TypeError, introspect the installed package and adapt the example to match the actual API rather than retrying.

CRISPResso2 Editing Quantification

"Quantify CRISPR editing from my amplicon sequencing" -> Align amplicon reads against the reference, classify each read as unmodified / NHEJ / HDR / base-edited / prime-edited within the quantification window, and report per-edit-type frequencies, indel size distributions, allele-frequency tables, and substitution-position profiles.

  • CLI: CRISPResso -- single amplicon, single sample
  • CLI: CRISPRessoBatch -- multi-sample with per-sample parameters
  • CLI: CRISPRessoPooled -- multi-amplicon pooled amplicon sequencing
  • CLI: CRISPRessoWGS -- off-target quantification from whole-genome BAM
  • CLI: CRISPRessoCompare -- pairwise outcome comparison (e.g., treated vs untreated)

Mode Decision Tree

Experimental design Mode Key parameters
Single amplicon, single sample (e.g. pilot edit validation) CRISPResso --amplicon_seq, --guide_seq
Same amplicon, many samples (e.g. timecourse, dose response) CRISPRessoBatch --batch_settings table
Many amplicons, pooled in one library (e.g. arrayed validation pool) CRISPRessoPooled --amplicons_file
Off-target survey from whole-genome BAM CRISPRessoWGS --bam_file, --reference_file, --region_file
Comparing two CRISPResso runs (e.g. condition A vs B) CRISPRessoCompare two positional output folders
HDR / knock-in validation CRISPResso with --expected_hdr_amplicon_seq Same as base CRISPResso
Cytosine base editor (C->T) CRISPResso --base_editor_output --conversion_nuc_from C --conversion_nuc_to T
Adenine base editor (A->G) CRISPResso --base_editor_output --conversion_nuc_from A --conversion_nuc_to G
Prime editor (templated edit) CRISPResso with pegRNA parameters --prime_editing_pegRNA_spacer_seq, --prime_editing_pegRNA_extension_seq, --prime_editing_pegRNA_scaffold_seq

Fails when:

  • Pooled-amplicon mode applied to amplicons that share primer sequences -- reads get misassigned.
  • Base editor mode without specifying --conversion_nuc_from/--conversion_nuc_to -- defaults assume CBE (C->T); ABE runs will misclassify.
  • Prime editor mode without --prime_editing_pegRNA_extension_seq -- the RTT template is missing, no edit is detectable.

The Quantification Window

Why this matters for postdoc-level use: CRISPResso classifies reads as "edited" or "unmodified" based on whether modifications fall inside the quantification window (not the whole amplicon). The window is centered on the predicted cut site (Cas9: 3 bp upstream of PAM; Cas12a: 18 bp downstream of PAM) with a default size of 1. --quantification_window_size N extends N bp on EACH side, so the window is 2N bp wide.

# Default Cas9 setup
--quantification_window_size 1                  # 1-bp window at cut site
--quantification_window_center -3               # 3 bp upstream of PAM

# Base editor: widen window to cover editing positions 4-8
--quantification_window_size 10                 # 10 bp each side (20 bp total)
--quantification_window_center -10              # center on the editing window

Consequences of mis-sized window:

  • Too narrow: misses edits at HDR positions or far bystanders; underestimates editing
  • Too wide: includes random sequencing errors; inflates editing rate
  • Wrong center: edits at correct position are scored as outside the window

For base editing screens a widened window is conventional; CRISPResso2's own base-editor guidance uses --quantification_window_center -17 with a window sized to span the editing positions. For prime editing with multi-base templated edits, widen to encompass the entire edit region.

Single-Amplicon Cas9 Editing

Goal: Quantify indel frequencies and HDR efficiency from a single target site.

Approach: Align FASTQ reads to the reference and (optional) expected-HDR amplicon, classify each read, and report aggregated statistics.

CRISPResso \
    --fastq_r1 sample_R1.fastq.gz \
    --fastq_r2 sample_R2.fastq.gz \
    --amplicon_seq <amplicon_sequence_ref_genome> \
    --guide_seq <20nt_protospacer_no_PAM> \
    --expected_hdr_amplicon_seq <edited_amplicon_for_HDR> \  # OPTIONAL
    --quantification_window_size 1 \
    --quantification_window_center -3 \
    --min_average_read_quality 30 \                          # Phred quality filter
    --output_folder sample_results \
    --name sample_id

# Outputs:
#   sample_results/<name>/CRISPResso_mapping_statistics.txt
#   sample_results/<name>/CRISPResso_quantification_of_editing_frequency.txt
#   sample_results/<name>/Alleles_frequency_table.zip
#   sample_results/<name>/3a.<ref>.Indel_size_distribution.pdf
#   sample_results/<name>/4b.<ref>.Insertion_deletion_substitution_locations.pdf
#   (PDF by default; add --save_also_png for PNG)

--min_average_read_quality changes the reported editing percentage -- it is a real filter, not a neutral default. On one real test amplicon it dropped aligned reads 235->221 and shifted Modified% from 26.38% to 24.89%. Always report the retained-read fraction (READS ALIGNED / READS IN INPUTS after filtering, from CRISPResso_mapping_statistics.txt) alongside the editing percentage so a reader can see how much filtering happened.

Key outputs:

File Content
CRISPResso_mapping_statistics.txt Tab-separated, one data row: READS IN INPUTS, READS AFTER PREPROCESSING, READS ALIGNED, N_COMPUTED_ALN, ... (no percentage columns)
CRISPResso_quantification_of_editing_frequency.txt % unmodified, % NHEJ, % HDR (if expected), per-edit-class breakdown
Alleles_frequency_table.zip Per-allele sequences and frequencies (allele-level resolution)
Nucleotide_percentage_table.txt Per-position A/C/G/T/- frequencies (substitutions + deletions)
Quantification_window_nucleotide_percentage_table.txt Same, restricted to quantification window (base-editor analysis)

Base Editor Quantification

Goal: Distinguish target base conversion from bystander edits and indel byproducts.

Approach: Run CRISPResso with --base_editor_output flag and specify the conversion direction; widen the quantification window to cover the editing window.

# Cytosine Base Editor (CBE): C->T conversion
CRISPResso \
    --fastq_r1 cbe_sample.fastq.gz \
    --amplicon_seq <amplicon_seq> \
    --guide_seq <20nt_protospacer> \
    --base_editor_output \
    --conversion_nuc_from C \
    --conversion_nuc_to T \
    --quantification_window_size 10 \
    --quantification_window_center -10 \
    --output_folder cbe_results \
    --name cbe_sample

# Adenine Base Editor (ABE): A->G conversion
CRISPResso \
    --fastq_r1 abe_sample.fastq.gz \
    --amplicon_seq <amplicon_seq> \
    --guide_seq <20nt_protospacer> \
    --base_editor_output \
    --conversion_nuc_from A \
    --conversion_nuc_to G \
    --quantification_window_size 10 \
    --quantification_window_center -10 \
    --output_folder abe_results \
    --name abe_sample

Reading the output:

Metric Where Interpretation
Target editing % Quantification_window_nucleotide_percentage_table.txt, target C/A row Primary endpoint
Bystander editing % Same table, other C/A positions in window Off-target byproduct in window
Indel rate CRISPResso_quantification_of_editing_frequency.txt Cas9-like cut artifacts; should be <5% for clean BE
Substitution-vs-indel ratio Derived Ratio >10 indicates clean BE; <3 indicates cut-mediated mutagenesis instead

Critical: Bystander editing is intrinsic to base editors (the deaminase acts across a 5-nt window); it is not noise. Report bystander rates alongside target rates. See [[base-editing-analysis]] for variant-call implications.

Prime Editor Quantification

Goal: Quantify pegRNA-templated edits versus indel byproducts and partial edits.

Approach: Provide spacer, extension (PBS + RTT), and scaffold sequences; CRISPResso identifies reads matching the intended edit.

CRISPResso \
    --fastq_r1 pe_sample.fastq.gz \
    --amplicon_seq <amplicon_seq> \
    --guide_seq <20nt_protospacer> \
    --prime_editing_pegRNA_spacer_seq <20nt_protospacer> \
    --prime_editing_pegRNA_extension_seq <RTT+PBS_sequence> \
    --prime_editing_pegRNA_scaffold_seq <scaffold_sequence> \
    --output_folder pe_results \
    --name pe_sample

# Output adds:
#   Prime-editing outcomes are extra amplicon rows (Reference / Prime-edited / Scaffold-incorporated)
#   inside CRISPResso_quantification_of_editing_frequency.txt

Reading prime-editor output:

Metric Interpretation
Intended edit % The pegRNA-encoded edit was correctly installed
Scaffold incorporation % Reverse transcription read into scaffold instead of stopping at edit; failure mode
Indel % Nick-only editing without templated repair; common at low-PE-activity sites
Unmodified % Read matches the reference exactly

A high-quality prime-edit run shows intended-edit fraction >5% and scaffold incorporation <2%. See [[prime-editing-screens]] for pegRNA design rules.

Batch Mode (Multi-Sample, Same Amplicon)

Goal: Process tens to hundreds of samples with same amplicon design (e.g., a timecourse, dose response, or replicate panel).

Approach: Provide a tab-separated batch settings file with per-sample parameters; CRISPRessoBatch runs all in parallel.

# batch_settings.txt (tab-separated, headers required)
# name    fastq_r1                fastq_r2                amplicon_seq    guide_seq
# t0      t0_R1.fq.gz             t0_R2.fq.gz             ACGT...         GUIDE
# t6      t6_R1.fq.gz             t6_R2.fq.gz             ACGT...         GUIDE
# t12     t12_R1.fq.gz            t12_R2.fq.gz            ACGT...         GUIDE
# t24     t24_R1.fq.gz            t24_R2.fq.gz            ACGT...         GUIDE

CRISPRessoBatch \
    --batch_settings batch_settings.txt \
    --batch_output_folder batch_run \
    --skip_failed \
    --n_processes 8

# Outputs:
#   batch_run/CRISPRessoBatch_RUNNING_LOG.txt
#   batch_run/CRISPRessoBatch_quantification_of_editing_frequency.txt  (aggregated)
#   batch_run/CRISPResso_on_<name>/ for each sample

Pooled-Amplicon Mode

Goal: Process multi-amplicon sequencing libraries (e.g., arrayed validation pools).

Approach: Provide an amplicon table with one row per target; CRISPRessoPooled de-multiplexes reads to the correct amplicon.

# amplicons.txt (tab-separated; header may vary by CRISPResso2 version)
# amplicon_name  amplicon_seq    guide_seq
# BRCA1_exon3    ACGT...         GUIDE1
# TP53_exon7     ACGT...         GUIDE2
# KRAS_codon12   ACGT...         GUIDE3

CRISPRessoPooled \
    --fastq_r1 pooled_R1.fastq.gz \
    --fastq_r2 pooled_R2.fastq.gz \
    --amplicons_file amplicons.txt \
    --output_folder pooled_run \
    --min_reads_to_use_region 100 \                          # see note below
    --n_processes 8

# Outputs:
#   pooled_run/SAMPLES_QUANTIFICATION_SUMMARY.txt
#   pooled_run/CRISPResso_on_<amplicon>/ for each amplicon

--min_reads_to_use_region defaults to 1000. Any amplicon with fewer aligned reads than this is silently skipped -- CRISPRessoPooled still exits 0 and writes a complete-looking SAMPLES_QUANTIFICATION_SUMMARY.txt, but every field for that amplicon is NA (confirmed: a real 2-amplicon, ~250-reads/amplicon pilot pool -- exactly the "arrayed validation pool" use case this mode is for -- returns all-NA at the default). Set --min_reads_to_use_region below the expected per-amplicon read depth for pilot/validation-scale pools. Always check SAMPLES_QUANTIFICATION_SUMMARY.txt for NA rows before trusting the output.

Failure mode: Amplicons with shared primer regions get reads assigned to whichever amplicon comes first. Design primers with ≥3-bp distinguishing regions or use unique molecular identifiers.

WGS Off-Target Mode

Goal: Quantify off-target editing from whole-genome sequencing.

Approach: Provide BAM file + reference + BED file of suspected off-target sites; CRISPResso extracts reads from each region and quantifies edits.

CRISPRessoWGS \
    --bam aligned.bam \
    --reference genome.fa \
    --region_file off_targets.bed \
    --output_folder wgs_run \
    --n_processes 8

Use case: Validate empirically that an in vivo / clinical-grade edit has minimal off-target activity (combine with GUIDE-seq or CIRCLE-seq predicted sites).

Parse Output in Python

Goal: Pull editing metrics into downstream analysis or reports.

Approach: Read the tab-separated quantification files and the JSON metadata.

import pandas as pd
import json
from pathlib import Path

def parse_crispresso(output_dir):
    '''Extract key metrics from CRISPResso output directory.'''
    out = {}
    # Mapping statistics: 7-column, 2-row TSV (header + one data row); no percentage column,
    # so compute mapping_pct from READS ALIGNED / READS IN INPUTS.
    map_stats = pd.read_csv(Path(output_dir) / 'CRISPResso_mapping_statistics.txt', sep='\t').iloc[0]
    out['reads_in_input'] = int(map_stats['READS IN INPUTS'])
    out['reads_aligned'] = int(map_stats['READS ALIGNED'])
    out['mapping_pct'] = out['reads_aligned'] / out['reads_in_input'] * 100
    # Editing quantification
    quant = pd.read_csv(Path(output_dir) / 'CRISPResso_quantification_of_editing_frequency.txt', sep='\t')
    out['editing_quant'] = quant.set_index('Amplicon').to_dict()
    # JSON metadata
    info_path = Path(output_dir) / 'CRISPResso2_info.json'
    if info_path.exists():
        out['info'] = json.loads(info_path.read_text())
    return out

Failure Modes

Low alignment rate (<50%)

Trigger: Wrong amplicon sequence (off by one nt, wrong strand, primer-trimmed vs untrimmed). Mechanism: CRISPResso fails to align reads beyond the amplicon edges; discards as unmappable. Symptom: READS ALIGNED / READS IN INPUTS (from CRISPResso_mapping_statistics.txt, see parse_crispresso() above) <50%; per-position coverage drops at amplicon edges. Fix: Re-derive amplicon from genome at primer-trimmed boundaries; verify strand orientation; check that primers are NOT included in --amplicon_seq.

Total alignment failure (wrong locus / zero output)

Trigger: Amplicon sequence is from the wrong locus entirely (e.g. wrong gene), not just off-by-a-few-nt. Mechanism: No reads align at all; CRISPResso exits with a hard error instead of writing a graded result. Symptom: CRITICAL: Alignment error, please check your input. / ERROR: No alignments were found, exit code 1, no output folder written -- there is no percentage file to inspect in this case. Fix: Confirm the amplicon sequence actually corresponds to the intended target locus (BLAT/BLAST it against the reference genome) before re-checking primer trimming or strand.

High substitution rate but low indel (Cas9 sample)

Trigger: Sample contamination with adjacent amplicon, primer-dimer, or sequencing error inflation. Mechanism: Random substitutions inflate the per-position substitution rate without true indels. Symptom: Substitutions >2% at base positions outside the cut site; alignment metrics look fine. Fix: Increase --min_average_read_quality to 30+; filter contaminating amplicons; check primer-dimer in CRISPResso_RUNNING_LOG.txt.

Bystander C/A editing inflates "editing efficiency"

Trigger: Base-editor sample with wide quantification window; bystander Cs at adjacent positions counted as edits. Mechanism: Default --quantification_window_size 10 includes all positions in editing window; bystander edits are real but distinct from target edit. Symptom: Editing efficiency 80%+ but target SNV is 30%; bystander rate is 50%. Fix: Always read the per-position table (Quantification_window_nucleotide_percentage_table.txt), not just the aggregate. Report target and bystander rates separately. See [[base-editing-analysis]].

Prime editor sample with high scaffold incorporation

Trigger: RTT is too short relative to PBS, or pegRNA stops short. Mechanism: Reverse transcriptase reads past the edit into scaffold sequence; product is detectable but undesired. Symptom: Scaffold incorporation >5%; intended edit efficiency lower than expected. Fix: Re-design pegRNA with longer RTT; verify with PRIDICT2 (see [[prime-editing-screens]]).

MMEJ deletion misclassified as NHEJ

Trigger: Deletions with microhomology at junction; CRISPResso reports them as indels but doesn't distinguish MMEJ. Mechanism: MMEJ creates predictable deletions using flanking microhomologies; biologically distinct from random NHEJ. Symptom: Recurring same-size deletions in allele table (e.g., -7 bp deletion in 30% of reads). Fix: Examine Alleles_frequency_table for over-represented allele patterns; flag MMEJ-mediated deletions for interpretation (these may be inferred from indel hotspots).

Quantitative Thresholds

Threshold Value Source / Rationale
Cas9 editing efficiency (functional KO) >70% indels Field convention; below this, KO is incomplete
Indel rate (clean base editor) <5% Field convention; >5% = unwanted cut activity
Target conversion (CBE) >30% Variable by target; below this, screen power is poor
Target conversion (ABE) >30% ABE typically lower per-base than CBE
Bystander rate (BE) <10% acceptable; <5% ideal Application-dependent; for variant function studies, must be controlled
Intended-edit % (prime editor) >5% per-edit Field convention; can be 50%+ at favorable sites
Scaffold incorporation (PE) <2% High-quality pegRNA design
Alignment rate >85% Below this, amplicon design or contamination issue
Minimum read quality Phred 30 Q30 Illumina base-call-accuracy standard
Quantification window size (Cas9) 1 Clement 2019 default; precise cut-site analysis
Quantification window size (BE) 10 Cover editing window positions 4-13

Common Errors

Error / symptom Cause Solution
Alignment rate <50% Wrong amplicon sequence Re-verify; primers should NOT be in amplicon_seq
CRITICAL: No alignments were found, exit 1, no output folder Amplicon from the wrong locus entirely Confirm amplicon matches the intended target locus before re-checking trimming/strand
All reads "modified" Misaligned reference Check amplicon strand; reverse-complement test
BE shows mostly indels Cas9 contamination or wrong protein Re-derive cell line origin; check Cas9 vs nCas9-BE3
Inconsistent batch results Different amplicon_seq per sample Use CRISPRessoBatch with consistent amplicon
Pooled-amplicon misassignment Primer overlap between amplicons Re-design with ≥3-bp distinguishing regions
Pooled amplicon rows all NA Per-amplicon reads below --min_reads_to_use_region (default 1000) Lower --min_reads_to_use_region for pilot/validation-scale pools
Out-of-window edits ignored Window too narrow Increase --quantification_window_size
Scaffold incorporation high (PE) RTT too short Re-design pegRNA
Allele frequency dominated by 1 read Low input / clonal Verify input cell count; rerun if singleton

References

  • Clement K et al. 2019. Nat Biotechnol 37:224. CRISPResso2 algorithm and modes.
  • Pinello L et al. 2016. Nat Biotechnol 34:695. Original CRISPResso.
  • Anzalone AV et al. 2019. Nature 576:149. Prime editing (PE-1/PE-2/PE-3).
  • Komor AC et al. 2016. Nature 533:420. Base editing (BE3).
  • Findlay GM et al. 2018. Nature 562:217. Saturation genome editing.

Related Skills

  • crispr-screens/base-editing-analysis - Variant-function analysis using CRISPResso2 BE output
  • crispr-screens/prime-editing-screens - PRIDICT2 pegRNA design + PE-tiling
  • crispr-screens/library-design - sgRNA / pegRNA design for editing screens
  • crispr-screens/screen-qc - Editing-efficiency QC for variant interpretation
  • variant-calling/variant-annotation - Annotate detected variants downstream
  • read-alignment/bwa-alignment - For WGS off-target alignment input

04 同仓库更多 Skills

mrsonord2240
mrsonord2240/openscience-specialists

bio-workflows-metabolomics-pipeline

Orchestrates the untargeted LC-MS metabolomics pipeline end-to-end (xcms 4.x feature extraction, QC/drift/normalization, confidence-stratified annotation, permutation-validated statistics, background-aware pathway mapping), naming what each stage decides and where it silently fails. Use when running a full LC-MS metabolomics study from raw mzML to enriched pathways and needing the honest handoffs between stages. Each stage defers to its component skill for parameters and traps; for stable-isotope flux (a separate branch, not this untargeted flow) see metabolomics/isotope-tracing.

★ 2
mrsonord2240
mrsonord2240/openscience-specialists

bio-metabolomics-xcms-preprocessing

Programmatic untargeted LC-MS feature extraction in R with the modern xcms 4.x MsExperiment/XcmsExperiment API, taking raw mzML to a feature table via CentWave peak detection, retention-time alignment, peak-density correspondence, gap-filling, CAMERA redundancy collapse, and built-in QC feature filtering. Use when converting centroided LC-MS runs into a features-by-samples matrix and deciding centWave/grouping/alignment parameters. For drift correction and QC/CV filtering execution see metabolomics/normalization-qc; for metabolite identification see metabolomics/metabolite-annotation; for the MS-DIAL GUI alternative with MS2Dec deconvolution see metabolomics/msdial-preprocessing; for downstream statistics see metabolomics/statistical-analysis.

★ 2
mrsonord2240
mrsonord2240/openscience-specialists

bio-metabolomics-statistical-analysis

Decision-grade statistical analysis for metabolomics intensity tables. Covers transformation and scaling (Pareto vs unit-variance as a hidden hypothesis), unsupervised structure (PCA/HCA for QC), permutation-validated PLS-DA/OPLS-DA (R2 vs Q2, double CV, VIP as heuristic), univariate testing (Welch/Mann-Whitney/ANOVA/LMM with covariate adjustment), and dependence-aware multiple testing. Use when testing which metabolites differ, building or validating a discriminant model, choosing a scaling, or correcting many correlated tests. For sample-wise normalization/drift correction see metabolomics/normalization-qc; for ML classifiers and selection-inside-CV leakage see machine-learning/biomarker-discovery and machine-learning/model-validation; for pathway interpretation see metabolomics/pathway-mapping; for design/power/multiplicity regime see experimental-design/multiple-testing.

★ 2
mrsonord2240
mrsonord2240/openscience-specialists

bio-metabolomics-pathway-mapping

Maps metabolomics results to biological pathways via over-representation (ORA), metabolite-set enrichment (MSEA/QEA), mummichog/PSEA on raw m/z peaks, and network-diffusion enrichment (FELLA), with correct background-set construction and honest interpretive ceilings. Use when interpreting differential metabolites or an untargeted LC-MS feature table in pathway context, choosing ORA vs MSEA vs mummichog vs topology, or setting the reference/background set. For annotation confidence levels feeding ORA see metabolomics/metabolite-annotation; for gene-set concepts see pathway-analysis/go-enrichment and pathway-analysis/gsea; for joint gene+metabolite pathways see multi-omics-integration/mofa-integration.

★ 2
mrsonord2240
mrsonord2240/openscience-specialists

bio-metabolomics-normalization-qc

Designs QC, corrects signal drift, removes batch effects, filters features, normalizes samples, and imputes missing values for untargeted LC-MS/GC-MS metabolomics, framing each step as a measurement model that can create or erase biological signal. Use when processing a peak/feature table before statistical analysis, choosing a drift-correction or sample-normalization method, deciding QC RSD vs D-ratio filtering, or handling left-censored missing values. The feature table is produced by metabolomics/xcms-preprocessing or metabolomics/msdial-preprocessing; transformation/scaling for modeling defers to metabolomics/statistical-analysis; cross-study design issues link to experimental-design/batch-design.

★ 2
mrsonord2240
mrsonord2240/openscience-specialists

bio-metabolomics-msdial-preprocessing

Runs the MS-DIAL preprocessing workflow (peak picking, MS2Dec spectral deconvolution, alignment, gap-filling) and imports the alignment-result table into R or Python with honest filtering. Use when preprocessing LC-MS DDA/DIA (SWATH) or GC-MS raw data with MS-DIAL, deciding MS-DIAL vs XCMS, configuring the MSDIALCUI console run, or parsing an MS-DIAL export into a clean feature matrix. For programmatic R peak detection and the feature-table-as-artifact framing see metabolomics/xcms-preprocessing; for lipid annotation mode see metabolomics/lipidomics; for MSI-level confidence honesty see metabolomics/metabolite-annotation; for drift correction and QC see metabolomics/normalization-qc.

★ 2